Morbidity Associated with "self-rated Health" in Epithelial Ovarian Cancer Survivors

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2009 Jan 6

PMID 19121203

Citations 9

Authors

Astrid Helene Liavaag

Anne Dorum

Sophie D Fossa

Claes Trope

Alv A Dahl

Affiliations

Soon will be listed here.

Abstract

Background: Epithelial ovarian cancer survivors (EOCSs) frequently report multiple complaints after their treatment. The objective was to study somatic and mental morbidity in EOCSs associated with their Self-Rated Health (SRH) assessed by a single item.Findings were compared to age-matched controls from the general population.

Methods: In a cross -sectional follow-up design 189/287 (66%) EOCSs treated at The Norwegian Radiumhospital 1979-2003 responded to a mailed questionnaire on demographic data, and somatic and mental morbidity. SRH last week was rated on item #29 of the European Organization and Treatment of Cancer Quality of Life Questionnaire in 84/189 (97%) of responding EOCSs. For comparisons "good" and "poor" SRH groups were defined by the median score on the SRH item.

Results: EOCSs with "poor SRH" had higher level of somatic symptoms, anxiety, depression and fatigue than those with "good SRH" (p < .001). In multivariate analyses somatic symptoms, age and fatigue, were significantly associated with the SRH score in EOCSs, but not the cancer-related variables (FIGO stage, recurrence in < 6 months or chemotherapy ever). The model explained 70% of the variance in SRH in linear and 77% in logistic regression analyses. The distribution of the SRH scores in EOCSs did not differ significantly from that of normative controls; however a higher proportion of controls recorded a high SRH score.

Conclusion: SRH is strongly related to common somatic complaints, impairment and fatigue but not to cancer-related variables. A single question concerning SRH last week might be a quick screening method for collecting important information on symptoms in EOCSs, in addition to cancer-related questions.

Citing Articles

Survivors' health competence mediates the association between wearable activity tracker use and self-rated health: HINTS analysis.

De La Torre S, Spruijt-Metz D, Farias A J Cancer Surviv. 2022; 16(6):1268-1278.

PMID: 35001258 DOI: 10.1007/s11764-021-01112-9.

Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.

Lorusso D, Bologna A, Cecere S, De Matteis E, Scandurra G, Zamagni C Support Care Cancer. 2020; 28(5):2435-2442.

PMID: 32048043 DOI: 10.1007/s00520-020-05320-4.

Lived experiences and quality of life after gynaecological cancer-An integrative review.

Sekse R, Dunberger G, Olesen M, Osterbye M, Seibaek L J Clin Nurs. 2018; 28(9-10):1393-1421.

PMID: 30461101 PMC: 7328793. DOI: 10.1111/jocn.14721.

Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future.

Colombo N, Lorusso D, Scollo P Int J Gynecol Cancer. 2017; 27(6):1134-1140.

PMID: 28640766 PMC: 5499966. DOI: 10.1097/IGC.0000000000001023.

Zhou Y, Irwin M, Ferrucci L, McCorkle R, Ercolano E, Li F Gynecol Oncol. 2016; 141(3):543-549.

PMID: 27072805 PMC: 4913461. DOI: 10.1016/j.ygyno.2016.04.006.

References

Kristensen G, Trope C . Epithelial ovarian carcinoma. Lancet. 1997; 349(9045):113-7. DOI: 10.1016/S0140-6736(96)06071-0. View

Friedlander M . Prognostic factors in ovarian cancer. Semin Oncol. 1998; 25(3):305-14. View

Thirlaway K, Fallowfield L, Cuzick J . The Sexual Activity Questionnaire: a measure of women's sexual functioning. Qual Life Res. 1996; 5(1):81-90. DOI: 10.1007/BF00435972. View

Vistad I, Fossa S, Kristensen G, Mykletun A, Dahl A . The sexual activity questionnaire: pychometric properties and normative data in a norwegian population sample. J Womens Health (Larchmt). 2007; 16(1):139-48. DOI: 10.1089/jwh.2006.0052. View

Hopwood P, Fletcher I, Lee A, Al Ghazal S . A body image scale for use with cancer patients. Eur J Cancer. 2001; 37(2):189-97. DOI: 10.1016/s0959-8049(00)00353-1. View

Stewart D, Wong F, Duff S, Melancon C, Cheung A . "What doesn't kill you makes you stronger": an ovarian cancer survivor survey. Gynecol Oncol. 2001; 83(3):537-42. DOI: 10.1006/gyno.2001.6437. View

Eriksson I, Unden A, Elofsson S . Self-rated health. Comparisons between three different measures. Results from a population study. Int J Epidemiol. 2001; 30(2):326-33. DOI: 10.1093/ije/30.2.326. View

Lockwood-Rayermann S . Survivorship issues in ovarian cancer: a review. Oncol Nurs Forum. 2006; 33(3):553-62. DOI: 10.1188/06.ONF.553-562. View

Butt Z, Wagner L, Beaumont J, Paice J, Peterman A, Shevrin D . Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage. 2007; 35(1):20-30. DOI: 10.1016/j.jpainsymman.2007.02.040. View

10.

Liavaag A, Dorum A, Fossa S, Trope C, Dahl A . Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?. J Clin Oncol. 2007; 25(15):2049-56. DOI: 10.1200/JCO.2006.09.1769. View

11.

Shadbolt B, Barresi J, Craft P . Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol. 2002; 20(10):2514-9. DOI: 10.1200/JCO.2002.08.060. View

12.

Hjermstad M, Fayers P, Bjordal K, Kaasa S . Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). J Clin Oncol. 1998; 16(3):1188-96. DOI: 10.1200/JCO.1998.16.3.1188. View

13.

Krause N, Jay G . What do global self-rated health items measure?. Med Care. 1994; 32(9):930-42. DOI: 10.1097/00005650-199409000-00004. View

14.

Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

15.

Fayers P, Sprangers M . Understanding self-rated health. Lancet. 2002; 359(9302):187-8. DOI: 10.1016/S0140-6736(02)07466-4. View

16.

Wilhelm K, Parker G . The development of a measure of intimate bonds. Psychol Med. 1988; 18(1):225-34. DOI: 10.1017/s0033291700002051. View

17.

Rohrer J, Arif A, Denison A, Young R, Adamson S . Overall self-rated health as an outcome indicator in primary care. J Eval Clin Pract. 2007; 13(6):882-8. DOI: 10.1111/j.1365-2753.2006.00766.x. View

18.

Bjelland I, Dahl A, Haug T, Neckelmann D . The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002; 52(2):69-77. DOI: 10.1016/s0022-3999(01)00296-3. View

19.

Hilditch J, Lewis J, Peter A, van Maris B, Ross A, Franssen E . A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996; 24(3):161-75. DOI: 10.1016/s0378-5122(96)82006-8. View

20.

Fossa S, Hess S, Dahl A, Hjermstad M, Veenstra M . Stability of health-related quality of life in the Norwegian general population and impact of chronic morbidity in individuals with and without a cancer diagnosis. Acta Oncol. 2007; 46(4):452-61. DOI: 10.1080/02841860601182641. View